Chronic Lung Disease of Prematurity Withdrawn Phase 1 Trials for L-Citrulline (DB00155)

Also known as: Bronchopulmonary Dysplasia / Dysplasia, Bronchopulmonary / Ventilator lung in newborn / Congenital pulmonary fibrosis

IndicationStatusPhase
DBCOND0044076 (Chronic Lung Disease of Prematurity)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00742534Phase 1 Intravenous Citrulline for the Prevention of Bronchopulmonary Dysplasia in Preterm InfantsTreatment